Agathe W.
- Country
- France
- Department
- Institut de Cancerologie du Gard - Service Hematologie Clinique
Research Overview
- TRANSCRIPT: An open label, controlled, randomized multicentric international study evaluating the benefit of autologous stem cell transplantation after complete response in frontline setting patients with T cell-lymphoma
- Phase III Evaluation of Polatuzumab Vedotin with Rituximab, Gemcitabine, and Oxaliplatin in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- Phase 3 Randomized Study of Mezigdomide, Bortezomib, and Dexamethasone vs. Pomalidomide, Bortezomib, and Dexamethasone in Relapsed/Refractory Multiple Myeloma
Data & Insights
Has run more than one trial at 160 of 353 partner sites.
Specializations
Lymphoma Therapeutics
This investigator specializes in treating various forms of lymphoma, with particular focus on both B-cell and T-cell malignancies. Their research encompasses diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, and peripheral T-cell lymphoma.
- Novel Combination Therapies
- First-line Treatment Approaches
- Relapsed/Refractory Disease Management
The investigator explores innovative therapeutic combinations including targeted antibodies and conventional chemotherapy regimens.
Specialized Lymphoma Studies
Expertise extends to rare and complex lymphoma subtypes, including primary central nervous system lymphoma and advanced research in autologous stem cell transplantation for lymphoma patients.
- CNS Lymphoma Treatment
- Transplantation Strategies
- Response Assessment Protocols
Their work includes evaluation of novel therapeutic approaches for specific lymphoma subtypes and treatment-resistant cases.
Multiple Myeloma Research
The investigator conducts research in multiple myeloma treatment, specifically focusing on elderly patients who are transplant-ineligible. Their work involves evaluation of novel therapeutic combinations and treatment strategies.
- Elderly Patient Care
- Novel Drug Combinations
- Minimal Residual Disease Assessment
Special attention is given to developing treatment protocols suitable for non-frail elderly patients with newly diagnosed multiple myeloma.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.